{
    "code": "02025551",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025551",
    "time": "2022-06-10 07:33:45",
    "許可證字號": "衛署藥輸字第025551號",
    "註銷狀態": "已註銷",
    "註銷日期": "111\/06\/06",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/10",
    "發證日期": "100\/11\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202555102",
    "中文品名": "歐克力注射劑",
    "英文品名": "Oxaliplatin Hospira 5mg\/ml concentrate for solution for infusion",
    "適應症": "適應症變更(依據首家變更)\r\n和5-fluorouracil(5-FU)及folinic acid(FA)併用，作為-第三期結腸癌(Duke's C)原發腫瘤完全切除手術後的輔助療法。-治療轉移性結腸直腸癌。Oxaliplatin和Capecitabine併用可用於局部晚期及復發\/轉移性胃癌之治療。\r\n與5-fluorouracil、leucovorin及irinotecan合併治療(FOLFIRINOX)，作為轉移性胰臟癌之第一線治療藥物。",
    "劑型": "270注射劑",
    "包裝": "10毫升、20毫升小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OXALIPLATIN",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0567000  ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED",
            "製造廠廠址": "PHARMEZ SPECIAL ECONOMIC ZONE, PLOT NO.3, SARKHEJ-BAVLA ROAD, N.H. NO. 8A, VILLAGE: MATODA, TALUKA: SANAND, DISTRICT-AHMEDABAD-382 213 (GUJARAT), INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Oxaliplatin 50 mg vial-110-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Oxaliplatin-INS-090622-109-10-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=010&Type=9"
        },
        {
            "title": "Oxaliplatin 50 mg10ml carton-110-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=008&Type=8"
        },
        {
            "title": "Oxaliplatin 50 mg carton-110-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=007&Type=8"
        },
        {
            "title": "Oxaliplatin 50 mg10ml photos-109-07-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=006&Type=8"
        },
        {
            "title": "Oxaliplatin_100mg photo_20161114-105-11-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025551&Seq=005&Type=8"
        }
    ]
}